Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on ADHD and currently lists participation information in Sweden.
Multiple locations, including Enköping
This study is recruiting. It focuses on ADHD and currently lists participation information in Germany.
In Germany
This study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
Multiple locations, including SaralandThis study is recruiting in Japan. It is testing EB-1020 for ADHD.
In TokyoThis study is recruiting. It focuses on ADHD and currently lists participation information in Norway.
Multiple locations, including BergenThis study is recruiting. It focuses on ADHD and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in Sweden. It focuses on ADHD.
In UmeåThis study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In BaltimoreThis study is recruiting. It focuses on ADHD and currently lists participation information in Sudan, Suriname, and Turkey.
In SudanThis study is recruiting. It focuses on ADHD and currently lists participation information in China.
In ChinaThis study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In PittsburghThis study is recruiting. It focuses on ADHD and currently lists participation information in Switzerland.
In ZurichHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.